BCL2L11 and non-small cell lung carcinoma: Previous studies showed that low expression of Bim was closely related to the resistance of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) in non-small cell lung carcinomas (NSCLCs) [61].